ABSTRACT
Introduction
Irbesartan is an angiotensin II receptor antagonist used in the management of hypertension including treatment of renal disease in hypertensive type II diabetic patients. It possesses acidic tetrazole system and biphenyl system, does not have acidic side chain and even so it has good affinity for angiotensin II receptor because of hydrogen bonding with the carbonyl moiety of amide system [2] . Irbesartan is a non-peptide compound, chemically described as a 2-butyl-3-[p-(o-1H-tetrazol-5-phenyl)benzyl]-l ,3-diazaspiro [4.4] non-l -en-4-one. Its empirical formula is C25H28N6O, and the structural formula is shown in Fig.1 . Irbesartan is a white to offwhite crystalline powder with a molecular weight of 428.5. Irbesartan is slightly soluble in alcohol and methylene chloride and practically insoluble in water [3] . Several methods were developed for the estimation of aceclofenac by HPLC, visible and UV spectroscopy [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] individually or in combination. In the present research paper, attempt made to develop a new spectrophotometric method for the determination of Irbesartan. So far, no Area under Curve Spectrophotometric method has been reported for the estimation of Irbesartan from pharmaceutical dosage form. This paper deals with validation and development of a method by Area under Curve for the assay of Irbesartan from pharmaceutical dosage forms.
Materials and Methods
Irbesartan was a gift sample by orchid chemicals, Chennai, India was used without further purification. All chemicals and reagents used were of analytical grade and were purchased from Merck Chemicals, India.
Instrumentation
For all the spectrophotometric methods, Shimadzu model 1700 double beam UV-VIS spectrophotometer with spectral bandwidth of 1.8nm, wavelength accuracy of 2 nm and a pair of 1 cm matched quartz cells of 10 mm optical path length was used.
Experiment

Standard preparation of Irbesartan
Accurately weighed 100 mg of Irbesartan and transferred into 100 mL clean, dry, volumetric flask, add 50 mL of methanol, sonicated for 5 min, dilute to volume wi th methanol and filtered through 0.45 µm membrane filter. Take 2.5 mL from above solution and make up to 100 mL with methanol (25 µg/mL). The above solution was scanned from 200-400 nm.
Analysis of marketed formulation
Twenty tablets were weighed and average weight was calculated. These tablets were crushed and powdered in a glass mortar. The tablet powder equivalent to 150 mg of Irbesartan was accurately weighed, transferred to a 100 mL of volumetric flask and diluted up to mark with methanol. Sonicated for 15 min and filtered through 0.45 µm membrane filter. Further diluted to obtain a concentration of 50 µg/ml.
VALIDATION PARAMETERS Linearity Preparation of stock solution Standard preparation of Irbesartan
Accurately weighed 100 mg of Irbesartan and transferred into 100 mL clean, dry, volumetric flask, add 50 mL of methanol, sonicated for 5 min, dilute to volume with methanol and filtered through 0.45 µm membrane filter. Take 5 mL from above solution and make up to 100 mL with methanol. From this stock solution 5-25 µg/ml solution was prepared.
Limit of Detection:
The limit of detection (LOD) is defined as the lowest concentration of the analyte in a sample that can be detected, though not necessarily quantified. It was a limit test that specifies whether or not an analyte is above or below a certain value. It was expressed in a concentration at a specified signal-to-noise ratio, usually 3:1 ratio.
LOD= 3*σ/slope limit of Quantization
The limit of quantification (LOQ) defined as the lowest concentration of an analyte in a sample that can be determined with acceptable precision and accuracy under the stated operational conditions of the method.
LOQ= 10*σ/slope Robustness As part of the robustness, deliberate change in the flow rate and mobile phase composition was made to evaluate the impact on the method. The mixed standard solution is injected in two replicate and % RSD was calculated.
RESULTS AND DISCUSSIONS
UV spectroscopy method was established for the quantitative analysis of Irbesartan in bulk and formulation. Thus the proposed method is appropriate for the simultaneous determination of Irbesartan can be useful for the routine analysis of the drug.
UV-SPECROPHOTOMETRIC METHOD DEVELOPMENT Optimized Method
The diluents used is methanol AUC Method( Area Under Curve Method) Spectra of Irbesartan
The above spectra represents the AUC of Irbesartan from 203-211nm selected as the two a sampling wavelength.
VALIDATION PARAMETERS LINEARITY
Linearity study of Irbesartan was performed by preparing different concentrations of solution 5µg/mL, 10µg/mL, 15µg/mL, 20µg/mL and 25µg/mL. 
Concentration
Result
The drug obeys beer lambert's law. The calibration plot was observed it is linear in the range of 5-25 µg/mL for Irbesartan. The correlation co efficient was found to be 0.998.
Precision Intraday Precision Study
Method precision study of Irbesartan was performed by single analyst in different hours within in a day at the concentration of 25 µg/mL. 
Result
The %RSD should not be more than 2%. As per ICH guidelines in the present study, the % RSD for Irbesartan was found to be 1.77 %. The % RSD value indicates a good degree of precision within the specified range. This indicates the method is precise.
Interday Precision Study: (Ruggedness)
System precision of Irbesartan was performed in a three different days at the concentration of 50µg/mL. 
Result
The %RSD should not be more than 2%. As per ICH guidelines in the present study, the % RSD for Irbesartan was found to be 1.82%, 1.76 % and 1.72 %.
Accuracy
Accuracy study of Irbesartan was performed using methanol as solvent. LOD and LOQ determination is based on the standard deviation of the response and slope. LOD and LOQ of Irbesartan were found to be 28.46 μg/ml and 76.45 μg/ml respectively.
SUMMARY AND CONCLUSIONS
In the present work, we have developed a newer, simple, accurate and cost effective area under curve Spectrophotometric method for the effective quantitative determination of Irbesartan in bulk and pharmaceutical dosage form without the interferences of other constituent in the formulations.
Area under Curve Method
 Detection of λ max of Irbesartan was found to be 203-211 nm. The proposed method was validated as per ICH guidelines. The method validated data showing satisfactory results for method validation tested.  The method was found to be linear in the concentration ranges from 5-25 µg/mL for Irbesartan with correlation coefficient 0.998.  In precision study it was found that %RSD is less than 2% which indicated that the proposed method has good reproducibility.  In accuracy study the % recovery of Irbesartan in bulk drug samples was ranged 96.45-93.84%, which indicates that the method was accurate.  LOD and LOQ, the limit of detection (LOD) was found to be 28.46 µg/ml and Limit of quantitation 76.45µg/ ml.
Conclusion
The UV spectrophotometric AUC method developed for determination of Irbesartan was based on different analytical techniques, UV-Spectrophotometric, AUC method. The method was validated and found to be simple, sensitive, accurate, and precise in compliance to the limits stated in the ICH guidelines. Hence, we conclude that the method can be used successfully for routine analysis of pharmaceutical dosage forms containing Irbesartan. The proposed spectrophotometric method will not replace the presently known methods available for the analysis of Irbesartan. However, it can serve as an alternative where advanced instruments (e.g. HPLC) are not available for routine analysis.
